Article info
PDFOriginal research
Niraparib maintenance in frontline management of ovarian cancer: a cost effectiveness analysis
- Correspondence to Dr David A Barrington, Gynecologic Oncology, The Ohio State University, Columbus, OH 43210, USA; david.barrington{at}osumc.edu
Citation
Niraparib maintenance in frontline management of ovarian cancer: a cost effectiveness analysis
Publication history
- Received April 29, 2020
- Revision received July 8, 2020
- Accepted July 9, 2020
- First published August 4, 2020.
Article Versions
- You are currently viewing a Previous version of this article (6 October 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.